Image-based detection of FGFR3 fusion in urothelial bladder cancer
Imagene AI to Demonstrate Real-Time Biomarker Detection From H&E Images at ASCO 2022
June 01, 2022 10:44 ET | Imagene AI
CHICAGO, June 01, 2022 (GLOBE NEWSWIRE) -- Imagene AI, an emerging leader in the field of AI-based precision medicine for cancer, today announced that it will demonstrate its molecular and spatial...
Imagene logo.jpg
Imagene AI CEO Dean Bitan to Speak at FORTUNE Brainstorm Health 2022
May 09, 2022 09:49 ET | Imagene AI
Company co-founder will be interviewed May 11 by Bryan Walsh of Vox on the show’s mainstage Imagene’s deep learning algorithms use digital biopsy images to deliver real-time molecular and spatial...
Imagene AI team
Imagene AI Secures $21.5 Million to Push the Boundaries of Precision Medicine for Cancer
May 02, 2022 07:30 ET | Imagene AI
Imagene's proprietary deep learning algorithms reduce the time required for biomarkers detection from several weeks to two minutes – allowing more cancer patients to receive the most effective...